Crunching the numbers for ALB... Refresh in a moment for the full analysis.
ALBEMARLE CORP (ALB)
Healthcare
Deep Overvalued
weak
$179.45
Updated: 2026-04-12
39
TradeApes Score
reduce
Financial Strength
25
Stressed
Operating Trend
50
Mixed
Valuation
25
Stressed
Capital Allocation
55
Mixed
Risk
60
Healthy
Fair Value
$0.0
Sector Rank
#12
of 18
Key Findings
+
Free cash flow positive — business generates real spendable cash
−
Very high leverage — net debt/EBITDA above 5×
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.